Pharma Pulse: FDA Ends 40-Year Drought for Motion Sickness

Jan 05, 10:30 AM
Headliner
Share
Subscribe
In today’s Pharma Pulse, Vanda Pharmaceuticals secures landmark approval for Nereus, while Hoth Therapeutics files dual patents to tackle treatment-induced skin toxicities.
Share
Subscribe
Next
Pharma Pulse: GoodRx Rollout for Oral Wegovy; Major Reprieve for 340B Hospitals; Sanofi’s $2.5B AI Bet
Top episodes
Overcoming Supply Chain Challenges
by Pharma Pulse
Incorporating AI into Commercialization Plans
by Pharma Pulse
The Capabilities of a 3PL Provider
by Pharma Pulse